Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
JWK-008 by Chengdu Genevector Biotechnology for Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ): Likelihood of Approval
JWK-008 is under clinical development by Chengdu Genevector Biotechnology and currently in Phase I for Mucopolysaccharidosis I (MPS I) (Hurler...